Medium/Large Size Posterior Uveal Melanoma Active Not Recruiting Phase 2 Trials for Dacarbazine (DB00851)

IndicationStatusPhase
DBCOND0047816 (Medium/Large Size Posterior Uveal Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01143402Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the EyeTreatment